| RS1553609359 |
TRAF3IP1
|
Health Risk |
Likely pathogenic |
— |
| RS1553609515 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1553609675 |
TTN
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1553609795 |
RAF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, RASopathy |
| RS1553609870 |
RAF1
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Cardiovascular phenotype |
| RS1553609996 |
RAF1
|
Health Risk |
Likely pathogenic |
— |
| RS1553610155 |
RAF1
|
Health Risk |
Likely pathogenic |
Noonan syndrome, Noonan syndrome |
| RS1553610240 |
TRIP12
|
Health Risk |
Pathogenic |
— |
| RS1553610329 |
TRIP12
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553610371 |
DIS3L2
|
Health Risk |
Pathogenic |
Perlman syndrome, Perlman syndrome |
| RS1553610382 |
GLB1
|
Health Risk |
Pathogenic |
Infantile GM1 gangliosidosis, GM1 gangliosidosis type 3 |
| RS1553610553 |
GLB1
|
Health Risk |
Likely pathogenic |
Infantile GM1 gangliosidosis, GM1 gangliosidosis type 3 |
| RS1553610974 |
THRB
|
Health Risk |
Pathogenic |
Thyroid hormone resistance, generalized |
| RS1553610984 |
THRB
|
Health Risk |
Likely pathogenic |
Thyroid hormone resistance, generalized |
| RS1553611016 |
GLB1
|
Health Risk |
Likely pathogenic |
GM1 gangliosidosis type 3, Mucopolysaccharidosis |
| RS1553611025 |
GLB1
|
Health Risk |
Pathogenic |
Infantile GM1 gangliosidosis, GM1 gangliosidosis type 3 |
| RS1553611038 |
THRB
|
Health Risk |
Pathogenic |
Thyroid hormone resistance, generalized |
| RS1553611040 |
GLB1
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-IV-B |
| RS1553611044 |
GLB1
|
Health Risk |
Likely pathogenic |
GM1 gangliosidosis type 3, Mucopolysaccharidosis |
| RS1553611055 |
GLB1
|
Health Risk |
Likely pathogenic |
Infantile GM1 gangliosidosis, GM1 gangliosidosis type 3 |
| RS1553611075 |
THRB
|
Health Risk |
Pathogenic |
Thyroid hormone resistance, generalized |
| RS1553611083 |
THRB
|
Health Risk |
Pathogenic |
Thyroid hormone resistance, generalized |
| RS1553611086 |
THRB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1553611094 |
THRB
|
Health Risk |
Pathogenic |
Thyroid hormone resistance, generalized |
| RS1553611773 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS1553611778 |
GLB1
|
Health Risk |
Likely pathogenic |
GM1 gangliosidosis type 3, Mucopolysaccharidosis |
| RS1553611789 |
GLB1
|
Health Risk |
Likely pathogenic |
Infantile GM1 gangliosidosis, GM1 gangliosidosis type 3 |
| RS1553611876 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS1553611909 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS1553611947 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Alport syndrome |
| RS1553611989 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiomyopathy, Cardiomyopathy |
| RS1553612005 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1553612082 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1553612117 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1553612143 |
GLB1
|
Health Risk |
Likely pathogenic |
Infantile GM1 gangliosidosis, Mucopolysaccharidosis |
| RS1553612145 |
GLB1
|
Health Risk |
Pathogenic |
GM1 gangliosidosis type 3, Mucopolysaccharidosis |
| RS1553612150 |
GLB1
|
Health Risk |
Pathogenic |
GM1 gangliosidosis type 3, Mucopolysaccharidosis |
| RS1553612158 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1553612164 |
BARD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1553612184 |
BARD1
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1553612188 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1553612189 |
GLB1
|
Health Risk |
Pathogenic/Likely pathogenic |
GM1 gangliosidosis type 3, Mucopolysaccharidosis |
| RS1553612205 |
BARD1
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS1553612213 |
GLB1
|
Health Risk |
Likely pathogenic |
GM1 gangliosidosis type 3, Mucopolysaccharidosis |
| RS1553612216 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1553612220 |
GLB1
|
Health Risk |
Pathogenic/Likely pathogenic |
GM1 gangliosidosis type 3, Mucopolysaccharidosis |
| RS1553612222 |
BARD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1553612309 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Benign familial hematuria |
| RS1553612321 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553612358 |
TRIP12
|
Health Risk |
Pathogenic |
Clark-Baraitser syndrome, Clark-Baraitser syndrome |
| RS1553612386 |
TTN
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553612433 |
COL4A4
|
Health Risk |
Pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS1553612461 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1553612499 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS1553612617 |
COL7A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Recessive dystrophic epidermolysis bullosa, Epidermolysis bullosa |
| RS1553612629 |
LZTFL1
|
Health Risk |
Likely pathogenic |
— |
| RS1553612904 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1553612928 |
COL7A1
|
Health Risk |
Likely pathogenic |
Epidermolysis bullosa dystrophica, 7 conditions |
| RS1553612999 |
TTN
|
Health Risk |
Likely pathogenic |
6 conditions, 6 conditions |
| RS1553613022 |
RAF1
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Noonan syndrome 5 |
| RS1553613123 |
THRB
|
Health Risk |
Likely pathogenic |
— |
| RS1553613303 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS1553613528 |
COL7A1
|
Health Risk |
Pathogenic |
Epidermolysis bullosa dystrophica, Epidermolysis bullosa dystrophica |
| RS1553614300 |
TRIP12
|
Health Risk |
Pathogenic |
Clark-Baraitser syndrome, Clark-Baraitser syndrome |
| RS1553614310 |
CYP27A1
|
Health Risk |
Likely pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS1553614347 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Dilated cardiomyopathy 1G |
| RS1553614378 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553614449 |
CAV3
|
Health Risk |
Likely pathogenic |
— |
| RS1553614521 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS1553614642 |
ABHD5
|
Health Risk |
Pathogenic |
— |
| RS1553614863 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS1553614878 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS1553614952 |
BARD1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1553614963 |
BARD1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS1553614987 |
TTN
|
Health Risk |
Pathogenic |
— |
| RS1553615089 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1553615092 |
BARD1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1553615102 |
BARD1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1553615121 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1553615135 |
BARD1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1553615184 |
BARD1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1553615846 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1553616235 |
CYP27A1
|
Health Risk |
Likely pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS1553616253 |
CYP27A1
|
Health Risk |
Likely pathogenic |
Cholestanol storage disease, CYP27A1-related disorder |
| RS1553616312 |
CYP27A1
|
Health Risk |
Pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS1553616339 |
BARD1
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1553616352 |
BARD1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS1553616361 |
BARD1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1553616431 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1553616447 |
ABHD5
|
Health Risk |
Pathogenic |
— |
| RS1553616457 |
CYP27A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS1553616463 |
TRIP12
|
Health Risk |
Pathogenic |
Clark-Baraitser syndrome, Clark-Baraitser syndrome |
| RS1553616478 |
CYP27A1
|
Health Risk |
Likely pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS1553616508 |
CYP27A1
|
Health Risk |
Likely pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS1553616622 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1553617378 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553617407 |
TTN
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1553618323 |
SETD5
|
Health Risk |
Pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS1553618354 |
POMGNT2
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS1553619103 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |